의료용 AI 시장 예측(-2034년) : 제공 형태, 기술, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global AI in Healthcare Market is accounted for $30.0 billion in 2026 and is expected to reach $408.8 billion by 2034 growing at a CAGR of 38.6% during the forecast period. AI is transforming healthcare by improving diagnosis, personalized treatments, and patient management. Advanced algorithms process large datasets, enabling early disease detection and tailored care plans. AI applications support medical imaging analysis, predict health outcomes, and optimize hospital operations, minimizing mistakes and expenses. Virtual assistants enhance patient interaction and remote health monitoring. Additionally, AI speeds up drug development and clinical trials by quickly identifying promising candidates. With continuous innovation, AI ensures healthcare becomes more precise, efficient, and widely accessible, reshaping the patient care landscape and driving significant improvements in overall medical services.

According to Elsevier's Clinician of the Future 2025 report, over 40% of clinicians in India are now using AI technologies in their practice-a three-fold increase from 12% last year. This adoption rate is higher than the United States (36%) and the United Kingdom (34%), though lower than China (71%) and the Asia-Pacific average (56%).

Market Dynamics:

Driver:

Rising demand for personalized medicine

The demand for personalized healthcare is driving AI adoption, as advanced algorithms can process large-scale patient data-including genetics, lifestyle, and clinical history-to create individualized treatment plans. This ensures higher treatment effectiveness, fewer side effects, and better overall patient outcomes. AI tools also allow continuous monitoring of patients, enabling adjustments to therapies as needed. As healthcare shifts toward precision and tailored solutions, AI becomes essential for developing and delivering customized care. This trend significantly contributes to the expansion of the AI in healthcare market, reflecting the increasing importance of patient-specific treatment strategies.

Restraint:

High implementation costs

Introducing AI into healthcare systems requires substantial investment in technology, infrastructure, and skilled professionals. Hospitals, particularly in emerging economies, often encounter budget limitations that hinder broad adoption. Expenses related to model training, system integration, and continuous maintenance further increase costs. Smaller healthcare facilities may find it difficult to justify such financial commitments, limiting AI deployment. Although AI promises long-term efficiency and improved patient outcomes, the high initial expenditure and resource demands continue to act as major obstacles, restraining the widespread utilization of AI technologies in healthcare settings worldwide.

Opportunity:

Development of AI-powered drug discovery

AI presents a promising opportunity in drug discovery, expediting the detection of new compounds and assessing their safety and effectiveness. Advanced algorithms can process extensive biological and chemical data, significantly cutting the time and expense of traditional drug development. AI also aids in simulating clinical trials, predicting adverse effects, and determining optimal dosages. Pharmaceutical firms can utilize AI to create personalized therapies for specific patient groups. As the need for rapid, precise, and cost-efficient drug development increases, AI emerges as a transformative tool in revolutionizing pharmaceutical research and development on a global scale.

Threat:

Cyber security and data breach risks

Healthcare AI systems process large amounts of confidential patient information, making them vulnerable to cyberattacks. Data breaches can expose medical records, cause financial damage, and harm institutional reputation. Threats like ransomware or hacking can disrupt AI functionality and risk patient safety. Ensuring AI security demands continuous monitoring, strong encryption, and strict regulatory compliance, which are both costly and complex. These cybersecurity vulnerabilities represent a major threat to the AI in healthcare market, as compromised data can erode trust, reduce adoption rates, and deter healthcare providers from fully integrating AI solutions into clinical workflows.

Covid-19 Impact:

The COVID-19 outbreak greatly accelerated AI adoption in healthcare, as hospitals and clinics sought rapid, data-driven solutions. AI tools were used for virus detection, predicting outbreaks, patient triage, and optimizing resource allocation in strained healthcare systems. Machine learning analyzed large datasets to forecast infection trends, identify high-risk areas, and support effective treatment planning. Telehealth and remote monitoring surged, with AI enabling virtual consultations and continuous patient management. The pandemic emphasized the value of scalable and intelligent healthcare solutions, acting as a catalyst that increased investment, acceptance, and integration of AI technologies across the global healthcare sector.

The machine learning (ML) segment is expected to be the largest during the forecast period

The machine learning (ML) segment is expected to account for the largest market share during the forecast period because it can process large healthcare datasets, identify patterns, and provide predictive insights. ML is extensively applied in diagnostics, personalized treatments, patient risk evaluations, and predictive healthcare analytics. By analyzing historical and current patient information, ML supports precise disease detection, monitoring, and outcome forecasting. Its use extends to medical imaging, drug development, and optimizing clinical operations. Due to its adaptability, efficiency, and measurable results, ML remains the leading segment, playing a central role in driving the growth and implementation of AI technologies across healthcare systems globally.

The precision medicine (genomics) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the precision medicine (genomics) segment is predicted to witness the highest growth rate, driven by its ability to provide personalized therapies based on genetic information. AI analyzes genomic data, detects mutations, and predicts how patients will respond to treatments, allowing tailored care. Increasing interest in targeted therapies, advances in genomics research, and AI integration in personalized medicine contribute to its rapid growth. This segment also enhances drug development, preventive care, and early detection of diseases.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, owing to its advanced medical infrastructure, widespread adoption of digital health technologies, and strong investment in AI research. The region benefits from the presence of leading tech and pharmaceutical firms, as well as government support promoting AI in healthcare. High provider awareness and substantial funding for AI-driven startups and clinical applications drive growth. With emphasis on precision medicine, telehealth, and data-centric healthcare solutions, North America maintains its position as the largest and most influential market for AI adoption in healthcare worldwide.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, fueled by rapid digitalization, expanding healthcare infrastructure, and increased AI adoption. Government programs promoting intelligent healthcare, rising investments in AI-driven startups, and growing patient demand contribute to this growth. AI applications across diagnostics, telehealth, personalized medicine, and patient care are quickly expanding. The region benefits from cost-efficient healthcare, technological progress and greater awareness among clinicians and patients, making Asia-Pacific the highest growth rate market in AI healthcare and a key hub for innovation and adoption of AI solutions globally.

Key players in the market

Some of the key players in AI in Healthcare Market include Aidoc, Tempus, Teladoc Health, GE Healthcare, Siemens Healthineers, Philips Healthcare, Google, NVIDIA, Medtronic, IBM, Microsoft, Oracle, Epic Systems, K Health, Owkin, PathAI, Abridge and Butterfly Network.

Key Developments:

In January 2026, Microsoft Corp has been awarded a $170,444,462 firm-fixed-price task order for the Cloud One Program by the U.S. Department of War. The contract will provide Microsoft Azure cloud service offerings to support the Air Force's Cloud One Program and its customers. Work on the project will be performed at Microsoft's designated facilities across the contiguous United States.

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In December 2025, IBM and Confluent, Inc. announced they have entered into a definitive agreement under which IBM will acquire all of the issued and outstanding common shares of Confluent for $31 per share, representing an enterprise value of $11 billion. Confluent provides a leading open-source enterprise data streaming platform that connects processes and governs reusable and reliable data and events in real time, foundational for the deployment of AI.

Offerings Covered:

• Hardware
• Software
• Services

Technologies Covered:

• Machine Learning (ML)
• Natural Language Processing (NLP)
• Computer Vision

Applications Covered:

• Diagnostics
• Precision Medicine (Genomics)
• Drug Discovery & Development
• Patient Monitoring & Care
• Healthcare Operations Optimization

End Users Covered:

• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Insurance & Home Healthcare Providers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global AI in Healthcare Market, By Offering

• 5.1 Hardware
• 5.2 Software
• 5.3 Services

6 Global AI in Healthcare Market, By Technology

• 6.1 Machine Learning (ML)
• 6.2 Natural Language Processing (NLP)
• 6.3 Computer Vision

7 Global AI in Healthcare Market, By Application

• 7.1 Diagnostics
• 7.2 Precision Medicine (Genomics)
• 7.3 Drug Discovery & Development
• 7.4 Patient Monitoring & Care
• 7.5 Healthcare Operations Optimization

8 Global AI in Healthcare Market, By End User

• 8.1 Hospitals & Clinics
• 8.2 Pharmaceutical & Biotechnology Companies
• 8.3 Academic & Research Institutes
• 8.4 Insurance & Home Healthcare Providers

9 Global AI in Healthcare Market, By Geography

• 9.1 North America
  • 9.1.1 United States
  • 9.1.2 Canada
  • 9.1.3 Mexico
• 9.2 Europe
  • 9.2.1 United Kingdom
  • 9.2.2 Germany
  • 9.2.3 France
  • 9.2.4 Italy
  • 9.2.5 Spain
  • 9.2.6 Netherlands
  • 9.2.7 Belgium
  • 9.2.8 Sweden
  • 9.2.9 Switzerland
  • 9.2.10 Poland
  • 9.2.11 Rest of Europe
• 9.3 Asia Pacific
  • 9.3.1 China
  • 9.3.2 Japan
  • 9.3.3 India
  • 9.3.4 South Korea
  • 9.3.5 Australia
  • 9.3.6 Indonesia
  • 9.3.7 Thailand
  • 9.3.8 Malaysia
  • 9.3.9 Singapore
  • 9.3.10 Vietnam
  • 9.3.11 Rest of Asia Pacific
• 9.4 South America
  • 9.4.1 Brazil
  • 9.4.2 Argentina
  • 9.4.3 Colombia
  • 9.4.4 Chile
  • 9.4.5 Peru
  • 9.4.6 Rest of South America
• 9.5 Rest of the World (RoW)
  • 9.5.1 Middle East
    • 9.5.1.1 Saudi Arabia
    • 9.5.1.2 United Arab Emirates
    • 9.5.1.3 Qatar
    • 9.5.1.4 Israel
    • 9.5.1.5 Rest of Middle East
  • 9.5.2 Africa
    • 9.5.2.1 South Africa
    • 9.5.2.2 Egypt
    • 9.5.2.3 Morocco
    • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

• 10.1 Industry Value Network and Supply Chain Assessment
• 10.2 White-Space and Opportunity Mapping
• 10.3 Product Evolution and Market Life Cycle Analysis
• 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

• 11.1 Mergers and Acquisitions
• 11.2 Partnerships, Alliances, and Joint Ventures
• 11.3 New Product Launches and Certifications
• 11.4 Capacity Expansion and Investments
• 11.5 Other Strategic Initiatives

12 Company Profiles

• 12.1 Aidoc
• 12.2 Tempus
• 12.3 Teladoc Health
• 12.4 GE Healthcare
• 12.5 Siemens Healthineers
• 12.6 Philips Healthcare
• 12.7 Google
• 12.8 NVIDIA
• 12.9 Medtronic
• 12.10 IBM
• 12.11 Microsoft
• 12.12 Oracle
• 12.13 Epic Systems
• 12.14 K Health
• 12.15 Owkin
• 12.16 PathAI
• 12.17 Abridge
• 12.18 Butterfly Network